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Abstract
Background: MicroRNAs are non-coding RNAs that regulate gene expression including differentiation and
development by either inhibiting translation or inducing target degradation. The aim of this study is to determine
the microRNA expression signature during human pancreatic development and to identify potential microRNA
gene targets calculating correlations between the signature microRNAs and their corresponding mRNA targets,
predicted by bioinformatics, in genome-wide RNA microarray study.
Results: The microRNA signature of human fetal pancreatic samples 10-22 weeks of gestational age (wga), was
obtained by PCR-based high throughput screening with Taqman Low Density Arrays. This method led to
identification of 212 microRNAs. The microRNAs were classified in 3 groups: Group number I contains 4 microRNAs
with the increasing profile; II, 35 microRNAs with decreasing profile and III with 173 microRNAs, which remain
unchanged. We calculated Pearson correlations between the expression profile of microRNAs and target mRNAs,
predicted by TargetScan 5.1 and miRBase altgorithms, using genome-wide mRNA expression data. Group I
correlated with the decreasing expression of 142 target mRNAs and Group II with the increasing expression of 876
target mRNAs. Most microRNAs correlate with multiple targets, just as mRNAs are targeted by multiple microRNAs.
Among the identified targets are the genes and transcription factors known to play an essential role in pancreatic
development.
Conclusions: We have determined specific groups of microRNAs in human fetal pancreas that change the degree
of their expression throughout the development. A negative correlative analysis suggests an intertwined network
of microRNAs and mRNAs collaborating with each other. This study provides information leading to potential two-
way level of combinatorial control regulating gene expression through microRNAs targeting multiple mRNAs and,
conversely, target mRNAs regulated in parallel by other microRNAs as well. This study may further the
understanding of gene expression regulation in the human developing pancreas.
Background
MicroRNAs are small non-coding RNAs [1-3] that act
mostly as translational repressors through binding to
partially complementary sequences of target messenger
RNAs. Recent studies indicate that in some cases micro-
RNAs might act also as positive regulators of translation
and transcription [4,5]. To date, more than 700 human
microRNAs are annotated in the Wellcome Trust
Sanger Institute microRNA database [6]. MicroRNAs
play a fundamental role in regulation of gene expression,
consequently affecting key biological events such as
embryogenesis, stem cell proliferation/differentiation
and organ development [7]. The method of conditional
knockout of the microRNA-processing enzyme Dicer
has been used to study the action of microRNAs in spe-
cific tissues and organs. This approach has confirmed
that the expression of microRNAs is essential for mor-
phogenesis of several systems, including the lungs,
limbs, muscle, skin and neuronal development and dif-
ferentiation [8-12] including the genesis of pancreatic
islet cells [13]. Dicer-null animals displayed gross defects
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in all pancreatic lineages; the most dramatic reduction
was seen in the endocrine cells, especially the insulin-
producing beta cells. Another approach utilized to assess
the role of microRNAs in organs/tissues is the loss of
function, i.e., silencing or knock out of a single or clus-
ter microRNAs. For instance, genetic deletion of the
miR-1/miR-133 cluster, showed its crucial role in car-
diac skeletal muscle development [14]. Several micro-
RNAs have been described in the context of pancreatic
development, pancreatic exocrine/endocrine microRNA
expression or islet biology/physiology. For example,
knockdown of miR-375, an islet microRNA that nega-
tively controls insulin secretion [15], has a deleterious
effect on the developing pancreas of zebra fish [16].
Mice lacking miR-375 (375KO) are hyperglycemic and
exhibit an increase in total pancreatic alpha-cell num-
bers, whereas the pancreatic beta-cell mass is decreased
[17]. Recent studies indicate that during human pan-
creatic development miR-7, miR-9, miR-375 and miR-
376 are specific islet microRNAs expressed at high levels
[18,19]. MiR-124a is known to target FOXA2 the tran-
scription factor crucial for early pancreatic formation
[20] by affecting genes such as PDX1, KCNJ11 (Kir6.2)
and SUR1, essential for the normal development of the
pancreas, glucose metabolism and insulin secretion [21],
while miR-15a, -15b, -16 and -195 have important roles
in regulating translation of NGN3, a transcription factor
affecting the adoption of an endocrine fate during
embryogenesis [22].
Research conducted over the last decade has outlined
rather comprehensive “roadmap” of the major molecular
events that shape mouse islet development [23,24].
Development of the human endocrine pancreas has not
been studied as well as that of the mouse. The previous
work has described expression of endocrine hormones
as well as transcription factors, and presented morpho-
logical examination of islet formation during human
fetal pancreatic development [25-29].
In this study we investigated the global expression
profile of microRNAs in the human fetal pancreas from
age 10 to 22 weeks of gestational age (wga) and found
212 microRNAs expressed throughout this entire period.
Understanding the complex processes behind pancreatic
development will require the identification of RNA tar-
gets that are controlled by the extensive microRNA net-
work expressed throughout the process. To identify
potential microRNA gene targets, we calculated the cor-
relations between the expression profile of these 212
microRNAs and their corresponding mRNA targets, pre-
dicted by bioinformatic tools, that were found in the
genome-wide RNA microarray study by Sarkar et al.
[28]. These studies will advance our understanding of
pancreatic development, potentially unveiling prospec-
tive therapeutic targets to treat diabetes.
Results and discussion
MicroRNA Expression profile during pancreatic
development
Using TaqMan Low Density Arrays (TLDA) from
Applied Biosystems we have performed microRNA
arrays with 10 samples acquired at different stages of
human fetal pancreatic development. Specifically; 10
wga (two samples), 11 wga (one sample), 13 wga(one
sample), 14 wga (three samples), 15 wga (one sample),
21 wga (one sample), 22 wga (one sample). The TLDA
platform has been selected because it requires smaller
amounts of RNA ~100 ng per experiment, which is
about ~20 times less than what is required for other
microarray hybridization platforms, furthermore it deli-
vers quantitative output. We identified 212 microRNAs
expressed throughout all studied gestational ages. Inter-
estingly several microRNAs reported previously in stu-
dies of mouse pancreatic development/regeneration and
islet function were also found expressed during human
pancreatic development (Table 1).
For the correlation analysis we arranged the samples in
3 gestational periods: 10-11wga (three samples); 13-15
wga (five samples) and 21-22 wga (two samples) and clas-
sified the microRNAs in three groups according to their
expression profile (Material and Methods). Groups I and
II contain 4 and 35 microRNAs respectively. Their statis-
tically significant (p < 0.05) expression change was either
up-regulated (group I) or down-regulated (group II) at
least from one gestational stage to the other. Group III
comprises of 173 microRNAs with expression relatively
unchanged (p > 0.05) (Table 2 & Additional file 1, Table
S1). Table 2 was prepared using relative quantification
(RQ) values normalized by nucleolar RNA (RNU48) as
endogenous control (Additional file 1, Table S1). RQ is a
measure of the abundance of microRNA transcripts at
each developmental stage. The microRNAs in Table 2
are arranged according to their descending RQ starting
at the stage 10 wga. MiR-7, miR-124, miR-9 and miR-
375, are microRNAs previously reported as related to
pancreatic islets [18-20]. We found that only statistically
significant increase of expression was for miR-7. miR-375
showed an increasing trend, however slightly below the
threshold value (p = 0.08), which might be the result of a
low sample number. Additional file 2, Table S2 shows
the average RQs for microRNAs in group I and II in each
gestational period.
A hierarchical cluster representation of microRNAs
clearly shows the pattern of expression of these three
groups (Figure. 1).
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Inverse correlation between microRNA and mRNA during
human pancreatic development
Although mechanistically, microRNAs inhibit mRNA
translation, the expression of a given microRNA has
also been associated with the downregulation of its tar-
get mRNA levels [30,31]. Therefore, to identify potential
microRNA targets, we performed a statistical analysis
looking for inverse correlations between the microRNAs
in groups I and II (a total of 39 microRNAs) and the
algorithm-predicted target genes that were found in a
human pancreatic development genome-wide mRNA
microarray gene expression study [28]. Predictive algo-
rithms are a powerful tool to identify potential RNA tar-
gets [32]. The target RNAs were selected by two of the
most commonly used computational microRNA predic-
tive target programs, miRBase [33] and TargetScan
[30,34]. There is a limitation to this kind of analysis
because it utilizes only the sequence correlation of
3’UTR mRNA domain with microRNA seed sequences.
This excludes naturally occurring microRNA targets
with recognition motifs within the gene coding
sequence. This kind of microRNA/mRNA interaction
has been recently reported as well [35]. Computational
predictions often generate long lists of target genes and
these are not always concordant [32]. Therefore, the
correlations were calculated with target genes predicted
by each program individually, and also by the intersec-
tion of both algorithms, as this might increase the odds
of identifying the bona fide RNA targets [36].
High confidence correlation (R2≥0.8) analysis between
microRNAs and gene targets identified 2832 and 9448
correlations using miRBase and TargetScan respectively
(Additional file 3, Table S3 and Additional file 4, Table
S4). A total of 1018 genes were identified as potential
targets by both predictive algorithms (Additional file 5,
Table S5); microRNAs from group I correlated with
decreased expression of 142 potential targets while
micoRNAs from group II, correlated with the increasing
expression of 876 potential targets (Table 3). For all
microRNA groups the number of targets predicted by
TargetScan was higher than by miRBase, which is in
agreement with previous observations [37,38].
Genes involved in pancreatic development correlated
with microRNAs
We searched for microRNAs that negatively correlated
with genes from signaling pathways and transcription
factors that are known to be involved in murine pan-
creatic development and/or regulate beta-cell develop-
ment [39] (Table 4). Out of the 28 candidate genes, 11
were identified as potential targets for microRNAs.
Most of the correlations corresponded to microRNAs
from group II. Ten genes up-regulated throughout the
development correlated with 19 decreasing microRNAs
from group II. Decreasing gene SOX4, was identified as
a potential target for miR-489 from group I. The identi-
fication of 19 microRNAs with decreasing expression
along the pancreatic development, thus contributing to
the upregulation of their potential targets, suggests a
collaborative network of microRNAs and mRNAs during
this period (Figure. 2). Most microRNAs target more
than one gene and conversely a given mRNA could be
the target of several microRNAs. For example, NEU-
ROD1, a key transcription factor involved in the
Table 1 MicroRNAs expressed during human fetal pancreatic development
miR-7 Expressed in pancreatic adult and fetal endocrine cells [18,19,30].
miR-375 Negative regulator of glucose-induced insulin secretion through myothrophin regulation [15]. miR-375 K/O mice are
hyperglycemic -more alpha cells; less beta-cells- [17]. Regulation of PI3 pathway by regulation of PDK1 in insulinoma
cells [31]. The miR-375 gene promoter directs expression selectively to endocrine pancreas [32].
miR-9 Expressed at high levels during islet development [19]. Target of transcription factor Onecut-2 impairing glucose-
induced insulin secretion in insulinoma cells.
miR-195; miR-16 miR-15a;
miR-15b
Role in pancreatic regeneration, possibly by targeting Ngn3 [22].
miR-124a Regulation of insulin secretion machinery and transcription factor Foxa2 in insulinoma cells [21,33].
miR-218 Expressed in mouse early fetal pancreas, controls the liver and pancreatic development regulator Onecut-2 in liver
embryonic cells [34].
miR-484; miR-107; miR-30d High glucose down-regulates their expression in insulinoma cells [35].
miR-146a Increased expression in islets from db/db obese mice, contributes to fatty acids-induced beta-cell dysfunction [36]. Pro-
inflammatory cytokines induce its expression in human islet and MIN6 cells [37].
miR-29a Over-expression induced insulin resistance in 3T3 adipocytes [38].
miR-503 miR-503 is expressed in a pattern similar to that of miR-375 in a mouse progenitor cells at e14.5 pancreas [13].
miR-376a Expressed at high levels during islet development [19].
miR-21; miR-34a Pro-inflammatory cytokines induce its expression in human islet and MIN6 cells [37]. miR-34a also contributes to fatty
acids-induced beta-cell dysfunction [36].
miR-96 Increases mRNA and protein levels of granulophilin, a negative regulator of insulin exocytosis [33].
These microRNAs have been previously described as expressed in adult or developing pancreatic tissue and/or having a functional role in islets/insulinoma cells.
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conversion of pancreatic progenitor cells into endocrine
cells [40] was identified as a potential target of five
microRNAs: miR-17-5p, miR-18a, miR-92, miR-103 and
miR-494. The decrease in the expression of these five
microRNAs would lead to the up-regulation of NEU-
ROD1. It is apparent that microRNAs can target genes/
transcription factors that have a role at different stages
of embryogenesis, for example miR-342 targets genes
such as GATA-4, involved in the formation of definitive
endoderm [41] and transcription factors FOXA2 and
MAFB both involved in beta-cell differentiation and
maturation [39,42].
Conclusions
In this study we determined the microRNA expression
signature during human pancreatic development, identi-
fying a total of 212 microRNAs expressed at least once
in one of the four stages evaluated (10 to 22 wga). To
further our understanding of gene expression regulation
in the human developing pancreas, we compared this
microRNA signature with the global expression of genes
during the similar period of the developing pancreas.
There are potential limitations to this kind of study that
should be considered: 1) the study was designed under
the assumption that microRNAs are associated with
Table 2 MicroRNA groups classified according to their expression profiles
Group I (4) Group II (35) Group III (173)
miR-7 miR-92 miR-26a miR-410 let-7g miR-142-5p miR-326
miR-141 miR-214 miR-19b miR-200b miR-148b miR-615 miR-488
miR-98 miR-484 miR-126 miR-433 let-7a miR-486 miR-629
miR-489 miR-125a miR-125b miR-142-3p miR-532 miR-143 miR-369-3p
miR-335 miR-30c miR-186 miR-379 miR-656 miR-496
miR-218 miR-16 miR-140 miR-565 miR-95 miR-133a
miR-99b miR-24 miR-152 miR-20b miR-490 miR-203
miR-342 miR-200c miR-411 miR-32 miR-101 miR-378
miR-382 miR-199a miR-365 miR-424 miR-107 miR-511
miR-301 miR-100 miR-374 miR-425-5p miR-193a miR-520g
miR-432 miR-99a miR-324-3p miR-361 miR-383 miR-17-3p
miR-181b miR-26b miR-27b miR-572 miR-193b miR-190
miR-323 miR-594 miR-10a miR-30e-5p miR-339 miR-450
miR-103 miR-127 miR-320 miR-423 let-7e miR-518b
miR-21 miR-20a miR-134 miR-10b let-7d miR-659
miR-130b miR-130a miR-429 miR-183 miR-372 miR-376b
miR-135b miR-30b miR-137 miR-146a miR-213 miR-338
miR-182 miR-30a-5p miR-149 miR-132 miR-491 miR-504
miR-181d miR-148a miR-324-5p miR-195 miR-503 miR-576
miR-25 miR-485-3p miR-145 miR-451 miR-224 miR-545
miR-17-5p miR-30d miR-151 miR-485-5p miR-500 miR-219
miR-296 miR-200a miR-210 miR-199b miR-493 miR-518e
miR-135a miR-19a miR-204 miR-23a miR-215 miR-642
miR-345 miR-223 miR-660 miR-194 miR-425 miR-196b
miR-299-5p miR-106b miR-328 miR-15a miR-1 miR-422a
miR-18a miR-331 miR-146b miR-181c miR-502 miR-518c
miR-369-5p miR-375 miR-192 let-7f miR-206 miR-337
miR-519d miR-197 miR-221 miR-340 miR-650 miR-189
miR-494 miR-191 let-7c miR-362 miR-29c miR-509
miR-550 miR-93 miR-30e-3p miR-22 miR-124a miR-299-3p
miR-187 miR-27a miR-9 miR-654 miR-452 miR-381
miR-409-5p miR-376a miR-30a-3p miR-330 miR-133b miR-329
miR-380-5p miR-487b miR-31 miR-155 miR-139 miR-518f
miR-512-3p miR-15b miR-28 miR-501 miR-29a
miR-96 miR-222 miR-23b hsa-let-7b miR-542-5p
MicroRNAs from group I and II increase and decrease their expressions respectively throughout the entire studied period. Group III includes microRNAs with
relatively constant expression throughout the period studied.
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downregulation of their targets. However, some micro-
RNAs were reported as positive regulators of transcrip-
tion or translation [4,5], 2) the correlation between
microRNAs and gene expression was performed with
mRNAs only, but there are some microRNAs that regu-
late only protein translation; 3) all potential targets were
identified by algorithms analyzing the 3’UTR of the
mRNA, while some microRNAs can also interact with
targets containing the recognition sequence in the coding
region; 4) the expression of microRNAs and mRNAs was
evaluated on different set of sample tissues, using differ-
ent platforms by different laboratories; 5) in this study we
have analyzed the pancreas as a whole, instead of looking
at the cellular subsets. Therefore, it is not possible to
determine if the observed changes corresponded to a spe-
cific cell population (e.g endocrine progenitors, mesench-
ymal tissue etc).
Despite of these caveats, the correlation between the
expression of hundreds of microRNAs with the analysis of
thousands of genes expressed during human pancreatic
development suggests the intertwined collaborative net-
work of microRNAs and mRNAs. It also provides broad
and useful information to explore potential two-way level
of gene expression control regulation in which microRNAs
target multiple mRNAs, and, target mRNAs are regulated
in parallel by multiple microRNAs. Ultimately, the specu-
lation regarding the roles of all these presumptive targets
will be justified only if they are experimentally validated.
Figure 1 Expression of microRNAs during human pancreatic development. The Heat- map figures were obtained using Cluster and
Treeview software [44] with the data presented in Additional file 1, Table S1. This table shows correlation among expression profiles of
microRNAs comprised into three groups from all studied fetal pancreatic samples; Group I, Group II and Group III. The color of each cell
represents the expression of microRNA normalized to small nucleolar RNU48 RNA. Colorgram depicts intensity of expression from high (bright
red) to low (black). Please note that even though in some cases the group III colorgram suggests a change of expression throughout the
gestational stages (e.g miR-376, miR-378, etc), these were found to be not statistically significant.
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Methods
Human fetal pancreas procurement
Human fetal pancreases from 10 to 22 weeks of gesta-
tional age (wga) were collected from fetal tissue immedi-
ately after elective termination of pregnancy. The healthy
women admitted to local clinics were properly informed
and gave their consent to use fetal tissues for research
studies. The study is in compliance with US legislation
and the guidelines of the University of Miami. Gesta-
tional age was determined on the basis of the last men-
strual period, with ultrasonographic measurements of the
Crown-Rump Length, and the biparietal diameter.
MicroRNA isolation
MicroRNA isolation was performed using mirVana
microRNA Isolation kit from Ambion/Applied Biosys-
tems (Foster City CA), following protocol for the total
RNA isolation procedure provided by the manufacturer.
Quantitative microRNA profiling: criteria for inclusion of
microRNAs in this study
We performed this study with 10 human fetal pancreases
of following gestational stages: two samples (10 wga); one
sample (11 wga); one sample (13 wga); three samples (14
wga); one sample (15 wga); one sample (21 wga) and one
Table 3 Correlation between microRNAs and gene targets
Genes Group I Genes Group II
miRNA TargetScan Sanger Shared miRNA TargetScan Sanger Shared
miR-141 318 99 53 miR-17-5p 433 121 65
miR-7 463 152 43 miR-181d 349 114 55
miR-489 209 95 34 miR-296 382 97 53
miR-98 105 55 12 miR-214 513 92 48
miR-103 384 115 46
miR-181b 284 88 46
miR-125a 385 100 45
miR-484 455 82 40
miR-345 263 71 34
miR-301 215 69 28
miR-182 291 77 27
miR-18a 231 98 27
miR-218 248 89 27
miR-342 417 72 24
miR-130b 221 92 23
miR-135a 231 74 23
miR-323 274 67 22
miR-494 385 47 22
miR-382 193 58 21
miR-432 241 60 21
miR-135b 190 59 19
miR-25 151 46 17
miR-92 200 67 17
miR-21 106 56 15
miR-299-5p 162 64 15
miR-335 220 45 14
miR-187 60 71 12
miR-512-3p 120 19 12
miR-519d 139 28 11
miR-550 150 31 11
miR-96 124 47 11
miR-409-5p 85 55 10
miR-99b 32 76 7
miR-380-5p 200 30 6
miR-369-5p 19 54 2
Total 1095 401 142 Total 8353 2431 876
Data for this table was obtained setting inverse correlations with R2 > = 0.80 as a cut off high confidence level.
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sample (22 wga). Total RNA was isolated using mirVana
microRNA Isolation kit, cDNA synthesis and the PCR
amplification was performed according to the manufac-
turer’s instructions (Applied Biosystems, Foster City,
CA). MicroRNA profiling was performed with micro flui-
dic cards TaqMan® Low Density Array (TLDA, v1.0) for
human microRNAs, which allows quantitative assess-
ment of 352 microRNAs using the AB7900 instrument
(Applied Biosystems). Quantitative values were calculated
as relative quantification (RQ), normalized to endogen-
ous control small nucleolar RNA RNU48, which is
expressed evenly in all samples. RQs were calculated with
SDS software supplied by the manufacturer (Applied Bio-
systems), utilizing the equation RQ = 2-ΔCt [43], where
Ct is the number of cycles at which the sample reaches a
software-determined threshold within the exponential
amplification phase. Ct ≥ 35 cycles was considered as
undetermined. The Gene Expression Omnibus (GEO)
accession number is GSE22026.
For the correlation analysis we arranged the samples
in 3 gestational periods: 10-11 wga; 13-15 wga and 21-
22 wga. Only microRNAs that amplified in 2 out 3 sam-
ples for 10-11 wga period, 4 out of 5 samples for 13-15
wga and 2 out of 2 samples in 21-22 wga were consid-
ered as positively expressed. Statistical analysis between
the groups: 10-11 wga vs 13-15 wga; 10-11 wga vs 21-22
wga and 13-15 wga vs 21-22 wga was performed with
two-tailed Student’s t test (Additional file 1, Table S1).
Values were considered significant when p < 0.05. The
microRNAs were classified according to their expression
profile into three groups. Group I contained microRNAs
with the expression increased at least from one gesta-
tional stage to the other (p < 0.05). Group II contained
microRNAs with the expression decreased at least from
one gestational stage to the other (p < 0.05). In group
III we included the microRNAs with the expression
unchanged throughout the studied gestational stages
(p > 0.05).
Table 4 Genes involved in pancreatic development correlated with microRNAs
Transcription factors Sanger TargetScan
Isl1 miR-182 (II) miR-382 (II), miR-432 (II)
Hlxb9 0 0
Hex 0 0






Sox9 0 miR-130b (II), miR-301 (II), miR-494 (II)
Sox4 0 miR-489 (I)
GATA-4 0 miR-187 (II), miR-214 (II), miR-342 (II)
GATA-6 0 0
Ngn3 0 0
NeuroD1 0 miR-17-5p (II), miR-18a (II), miR-92 (II), miR-103 (II), miR-494 (II)
Insm1 miR-99b (II) miR-99b (II), miR-345 (II), miR-494 (II)
Myt1 0 0
Pax6 miR-187 (II) miR-130b (II), miR-301 (II)
Pax4 0 0
Nkx2.2 miR-182 (II) 0
Nkx6.1 0 0
MafA 0 0
MafB 0 miR-181 d (II), miR-342 (II)
Foxa1 0 0




Data for this table was obtained setting inverse correlations with R2 > = 0.8 as a cut off high confidence level. Numbers in parenthesis indicates the microRNA
group.
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MicroRNA target gene databases
Two microRNA target databases were used in this ana-
lysis. One arch.v5.txt.homo_sapiens.zip, downloaded
from Sanger miRBase Targets http://microrna.sanger.ac.
uk/cgi-bin/targets/v5/download.pl; the other Nonconser-




mRNA gene expression files were retrieved from Sarkar
SA, Kobberup S, Wong R, Lopez AD, Quayum N, Still T,
Kutchma A, Jensen JN, Gianani R, Beattie GM et al:
Global gene expression profiling and histochemical
analysis of the developing human fetal pancreas [28].
22,000 genes were measured by 54,675 probe-sets on
Human Genome HG U133 Plus 2.0 microarrays (Affyme-
trix, Santa Clara, CA, USA). The mRNA hybridization
data from genes with multiple probes were averaged
prior to the correlation analysis. For the correlation ana-
lysis the Sarkar et al gene expression data were grouped
in three periods: 9, 10 and 11 wga (9-11); 15 wga; and 20,
23 wga. The gene expression of these three periods was
compared to the microRNA expression corresponding to
the three following periods: 10-11 wga; 13-15 wga and
21-22 wga. The Pearson correlation of the expression
profile between microRNA and a target gene was calcu-
lated in the R package. The correlation coefficient (r) was
calculated to determine the regulatory role of the micro-
RNA on its target genes. The correlation with r close to
-1 depicts a strong negative correlation between micro-
RNA and its target gene, indicating the suppression func-
tion of microRNA on its target gene. P-value is used to
test H0: r = 0. Benjamini-Hochberg FDR was used to cor-
rect the original p-value for multiple test correction. The
correlations with adjusted p-value < 0.05 are significant
Figure 2 Network of microRNA and mRNA targets. MicroRNAs (group I &II) and their predicted mRNA targets collaborate with each other
during pancreatic development.
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correlations, and among these correlations the ones with
(R2≥0.8) are significantly negative correlations where
microRNAs suppress the expression of target genes in
terms of expression in the three gestational ages.
Abbreviations of genes referenced in this study
Isl1: Insulin gene enhancer protein; Hlxb9: homeo box
HB9; Hex (Hhex):hematopoietically expressed homeobox
protein; Prox1: Homeobox prospero-like protein;
HNF1b: hepatocyte nuclear factor 1 homeobox B; HNF6:
hepatocyte nuclear factor 6; Ptf1a: Pancreas specific tran-
scription factor, 1a; Pdx1: Pancreatic and duodenal
homeobox 1; Pbx1: Pre-B-cell leukemia transcription fac-
tor 1; Sox9: transcription factor sox9; Sox4:transcription
factor sox4; GATA-4: transcription factor gata-4; GATA-
6: transcription factor gata-6; Ngn3: neurogenin-3;
NeuroD1: Neurogenic differentiation 1; Insm1: Insuli-
noma-associated protein 1; Myt1: Myelin transcription
factor 1; Pax6: Paired box gene 6: Pax4: Paired box gene
4; Nkx2.2: Homeobox protein Nkx-2.2; Nkx6.1: Homeo-
box protein Nkx-6.1; MafA: V-maf musculoaponeurotic
fibrosarcoma oncogene homolog a (avian); MafB: V-maf
musculoaponeurotic fibrosarcoma oncogene homolog b
(avian); Foxa1: forkhead box A1; Foxa2: forkhead box A2;
HNF1a: hepatocyte nuclear factor 1 homeobox A;
HNF4a: Hepatocyte nuclear factor 4 alpha; TCF7L2:
Transcription factor 7-like 2 (T-cell specific, HMG-box);
kir6.2: ATP-sensitive K+ channel; sur1: sulfonylurea
receptor 1.
Additional material
Additional file 1: Table S1: MicroRNA PCR array data of human
developing pancreas. PCR amplification cycles (CTs) were used to
calculate RQs using small nucleolar RNU48 RNA as endogenous control.
The t test between the different stages was calculated with individual
RQs.
Additional file 2: Table S2: Average RQ values for microRNAs
included in group I & II.
Additional file 3: Table S3: Correlation between microRNAs and
gene targets predicted by miRBase algorithm.
Additional file 4: Table S4: Correlation between microRNAs and
gene targets predicted by TargetScan algorithm.
Additional file 5: Table S5: Correlation between microRNAs and
gene targets predicted by both algorithms, miRBase and
TargetScan. In additional files 3, 4 and 5, the data for microRNAs are
average RQs. Data for genes are hybridization intensity values from
normalized arrays [28].
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